Sanofi has announced that newly established API manufacturer EuroAPI will begin trading on the Euronext Paris on 6 May, subject to shareholder approval at a meeting three days before. Following this, EuroAPI will operate independently.

“This important step towards our listing is a key milestone for EuroAPI and is part of the deployment of our strategy and our independence from Sanofi,” said CEO Karl Rotthier.

CDMO Seqens has confirmed that its planned change of ownership has been completed, with SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, becoming the majority shareholder.